title: Molecular forecasting of breast cancer: time to move forward with clinical testing.
authors.forename: Sherene
authors.initials: S
authors.lastname: Loi
authors.forename: Christos
authors.initials: C
authors.lastname: Sotiriou
authors.forename: Marc
authors.initials: M
authors.lastname: Buyse
authors.forename: Emiel
authors.initials: E
authors.lastname: Rutgers
authors.forename: Laura
authors.initials: L
authors.lastname: Van't Veer
authors.forename: Martine
authors.initials: M
authors.lastname: Piccart
authors.forename: Fatima
authors.initials: F
authors.lastname: Cardoso
mesh_terms: D014408:Biomarkers, Tumor / Q000235:genetics; D001943:Breast Neoplasms / Q000235:genetics*; D002986:Clinical Trials as Topic; D005260:Female; D005544:Forecasting; D005819:Genetic Markers; D020022:Genetic Predisposition to Disease; D005820:Genetic Testing; D006801:Humans; D009154:Mutation; D020411:Oligonucleotide Array Sequence Analysis; D011237:Predictive Value of Tests; D011379:Prognosis
chemical_list: D014408:Biomarkers, Tumor; D005819:Genetic Markers